T1DM, Type 1 diabetes mellitus
Accelerated demand after Mounjaros launch Even before Mounjaros momentous debut, Ozempic demonstrated notable HbA1c reductions and weight loss results, and demand for GLP-1s grew at a steady rate (compound monthly growth of 2% from January 2020 to May 2021)
Anatomy of Facial Volume Loss in Weight Reduction Understanding the nuances of facial anatomy is a critical first step in addressing volume loss in patients using GLP-1 agonists, said Sanja Cypen, MD, an oculofacial plastic surgeon at the Center for Excellence in Eye Care in Miami
About this article Cite this article Drucker, D.J
[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Nuijten M.A.H., Eijsvogels T.M.H., Monpellier V.M., Janssen I.M.C., Hazebroek E.J., Hopman M.T.E
Qatar Biobank This study was based on the second release of 14,060 Qatari participants (all from the same ancestry, MID) from the population-based Qatar Genome Program (QGP)